Table 3.
Parameters | Value | RSE (%) | 95% CI |
---|---|---|---|
Emax-placebo, % | 55.6 | 5.4 | 49.7, 61.5 |
Emax-estradiol, % | 44.9 | 7.0 | 38.7, 51.1 |
ET50-placebo, weeks | 1.96 | 11.4 | 1.5, 2.4 |
ET50-estradiol, weeks | 3.09 | 19.1 | 1.9, 4.2 |
η(Emax-placebo), % | 12.4 | 26.6 | 5.9, 18.9 |
η(Emax-estradiol), % | 12.3 | 39.1 | 2.9, 21.7 |
Correlation coefficient [η(Emax-placebo) – η(Emax-estradiol)] | 0.453 | – | – |
IAV, % | 0, Fixed | – | – |
ε, % | 46.2 | 14.4 | 33.2,. 59.2 |